Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

High-Intensity Focused Ultrasound (HIFU) Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21499

Download Sample Report
Published On

October 2021

Total pages

284

About the Report

Focused ultrasound is an initial phase, noninvasive therapeutic technology which improves the lives of millions of patients suffering from serious medical conditions. It provides a disruptive, life-changing complement to surgery, drug delivery, radiation therapy, and cancer immunotherapy. High-intensity Focused Ultrasound (HIFU) increases the quality and longevity of life and decreases the treatment cost. Nowadays, it is used in the treatment of a wide range of indications, including:

o Benign and malignant tumors of the brain, breast, prostate, liver, and pancreas
o Parkinson's and Alzheimer's diseases and epilepsy
o Depression and obsessive-compulsive disorder
o Arthritis and hypertension
o Uterine fibroids

In High-intensity focused ultrasound (HIFU) highly focused ultrasonic waves are applied to the local diseased tissue through ablation. This leads to the rise in temperature with the rising intensity of tissue vibrations. Once the temperature rises beyond 60 degrees Celsius, coagulative necrosis and protein denaturation happen which in turn leads to irreversible cell death. The advantages of using HIFU products in traditional ultrasound systems include less bleeding and low procedural time. Moreover, surgical procedures using these devices are minimally invasive, cost-effective, as well as less painful. There are currently more than 125 clinical indications in which HIFU is employed which are in various stages of development, and the number is growing rapidly. Globally, 31 indications have regulatory approval; in the US, while six have been approved by the FDA.

The demand for High-intensity focused ultrasound (HIFU) market is increasing on account of the high prevalence of cancer as well as cardiovascular disease cases, promulgating aging population, increasing number of new product launches, mounting number of clinical trials, and high focus of market key players on the development of technologically advanced systems. Moreover, the high recommendations by healthcare organizations (European Association of Urology, and the National Institute for Health and Clinical Excellence) on Focal therapy using the HIFU system for localized prostate cancer are encouraging market growth.

However, some of the restraints in the market are stringent government regulations for the approval of the HIFU system in the U.S. and unfavorable reimbursement scenario.

Based on Modality, the market is fragmented into Therapeutic Ultrasound, Hemostasis, Lithotripsy, Thrombolysis, Immunomodulation, and Others. The therapeutic ultrasound segment dominated the market in 2020 and is expected to grow at lucrative during the forecasted period. Therapeutic ultrasound is a kind of treatment modality that is mainly exploited during physical therapy to joints, tissue, muscles, tendons, and ligaments. It mainly provides deep heating to heel the soft tissues of the body. Therapeutic ultrasounds are used as two different effects such as deep heating effects and non-thermal effects. The deep heating process assists in providing heat energy to the soft tissues in the body and Non-thermal effects assist in the contraction and expansion of tissues known as cavitation. The therapeutic segment is primarily propelled by a rise in the number of ultrasound procedures, a high prevalence of chronic conditions, and technological advancements. Moreover, an increase in the incidence of various disorders such as respiratory disorders, cardiovascular diseases, and abdominal disorders drives the demand for therapeutic ultrasound devices. As per the World Health Organization (WHO), cardiovascular diseases (CVD) account for 9.4 million deaths globally each year. The number is likely to increase to 23.3 million by 2030.

Based on Methods, the market is bifurcated into Non-invasive Methods and Minimal Invasive Methods. The non-invasive segment dominated the market in 2020 and is expected to grow at lucrative during the forecasted period. Non-Invasive ultrasound stimulation is a developing technology that can noninvasively inhibit neural activity in the targeted brain by delivering pulsed ultrasonic waves. The increasing occurrence of the neurological, orthopedic, tooth, and gastrointestinal health problems among various chronic disorders is anticipated to create an upsurge in demand for non-invasive methods.

Based on Application, the market is bifurcated into Prostate Cancer, Uterine Fibroids, Neurological Disorders, Cosmetic Medicine, and Others. The uterine fibroids segment dominated the market in 2020 and is expected to grow at lucrative during the forecasted period. The rising incidents of Uterine fibroid are intensifying the segment growth. Uterine fibroid is the most common benign tumor in women of childbearing age. Around 25% of women and up to 30-40% of women older than 40 years have clinical symptoms of uterine fibroids. Many patients show clinical symptoms such as menorrhagia, irregular bleeding, pelvic pain, or infertility, which have a significant negative effect on their quality of life.

Based on End-users, the market is fragmented into Diagnostic Centers, Hospitals, Research Centers, and Others. The Hospitals segment dominated the market in 2020 and is expected to grow at lucrative during the forecasted period. The rising number of Hospitals and the high adoption of High-intensity focused ultrasound (HIFU) is driving the segment growth. Moreover, the rising prevalence of Diabetes cases all over the world is also driving the segment growth. In 2019, diabetes-related health expenditure was by far the highest in the United States, with roughly 295 billion U.S. dollars, followed by China with 109 billion and Brazil with 52 billion U.S. dollars. Globally, an estimated 760 billion U.S. dollars was spent on diabetes-related healthcare in 2019, meaning almost 40 percent of the global expenditures for the treatment of diabetes were spent in the United States. Global healthcare spending for the condition is projected to grow to an estimated 845 billion U.S. dollars by 2045.

For a better understanding of the market adoption of High-intensity focused ultrasound (HIFU), the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the High-intensity focused ultrasound (HIFU) market on account of the due to growing prevalence of cancers in this region, which is one of the major driving factors for the growth of high intensity focused ultrasound (HIFU) therapy market. Some of the major players operating in the market include Medtronic, Inc., Accutome, Inc., Sonacare Medical, Koninklijke Philips N.V., Johnson & Johnson, Stryker Corporation, Supersonic Imagine, Ultrasound Technologies Ltd., and Blatek, Inc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Scope of the Report

Products

Focused ultrasound is an initial phase, noninvasive therapeutic technology which improves the lives of millions of patients suffering from serious medical conditions.

Companies

Medtronic, Inc., Accutome, Inc., Sonacare Medical, Koninklijke Philips N.V., Johnson & Johnson, Stryker Corporation, Supersonic Imagine, Ultrasound Technologies Ltd., and Blatek, Inc.

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitation

1.3. Stake Holders

1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the High-intensity Focused Ultrasound (HIFU) Market

2.2. Research Methodology of the High-intensity Focused Ultrasound (HIFU) Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the High-intensity Focused Ultrasound (HIFU) Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET COVID-19 IMPACT

6 GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET REVENUE (USD), 2019-2027F

7 MARKET INSIGHTS BY MODALITY

7.1. Therapeutic Ultrasound

7.2. Hemostasis

7.3. Lithotripsy

7.4. Thrombolysis

7.5. Immunomodulation

7.6. Others

8 MARKET INSIGHTS BY METHODS

8.1. Non-invasive Method

8.2. Minimal Invasive Method

9 MARKET INSIGHTS BY APPLICATION

9.1. Prostate Cancer

9.2. Uterine Fibroids

9.3. Neurological Disorders

9.4. Cosmetic Medicine

9.5. Others

10 MARKET INSIGHTS BY END-USERS

10.1. Diagnostic Centers

10.2. Hospitals

10.3. Research Centers

10.4. Others

11 MARKET INSIGHTS BY REGION

11.1. North America High-intensity Focused Ultrasound (HIFU) Market

11.1.1. United States

11.1.2. Canada

11.1.3. Rest of North America

11.2. Europe High-Intensity Focused Ultrasound (HIFU) Market

11.2.1. Germany

11.2.2. U.K.

11.2.3. France

11.2.4. Spain

11.2.5. Rest of Europe

11.3. Asia Pacific High-Intensity Focused Ultrasound (HIFU) Market

11.3.1. China

11.3.2. Japan

11.3.3. India

11.3.4. Australia

11.3.5. Rest of Asia Pacific

11.4. Rest of World High-Intensity Focused Ultrasound (HIFU) Market

12 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET DYNAMICS

12.1. Market Drivers

12.2. Market Challenges

12.3. Impact Analysis

13 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET OPPORTUNITIES

14 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1. Demand Side Analysis

16.2. Supply Side Analysis

16.2.1. Top Product Launches

16.2.2. Top Business Partnerships

16.2.3. Top Business Expansions, Investments and Divestitures

16.2.4. Top Merger and Acquisitions

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

18.1. Competitive Landscape

18.1.1. Company Shares, By Revenue

19 COMPANY PROFILED

19.1. Medtronic, Inc.

19.2. Accutome, Inc.

19.3. Sonacare Medical

19.4. Koninklijke Philips N.V.

19.5. Johnson & Johnson

19.6. Stryker Corporation

19.7. Supersonic Imagine

19.8. Ultrasound Technologies Ltd.

19.9. Blatek, Inc.

20 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022